498 related articles for article (PubMed ID: 16797171)
1. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
[TBL] [Abstract][Full Text] [Related]
2. Adhesive properties: a critical issue in transdermal patch development.
Cilurzo F; Gennari CG; Minghetti P
Expert Opin Drug Deliv; 2012 Jan; 9(1):33-45. PubMed ID: 22171789
[TBL] [Abstract][Full Text] [Related]
3. [Transdermal therapeutic systems for drug administration].
Hupfeld S; Gravem H
Tidsskr Nor Laegeforen; 2009 Mar; 129(6):532-3. PubMed ID: 19282891
[TBL] [Abstract][Full Text] [Related]
4. Transdermal drug delivery system: patent reviews.
Samad A; Ullah Z; Alam MI; Wais M; Shams MS
Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):143-52. PubMed ID: 19519574
[TBL] [Abstract][Full Text] [Related]
5. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
Pfister WR; Hsieh DS
Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in transdermal drug delivery.
Subedi RK; Oh SY; Chun MK; Choi HK
Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
[TBL] [Abstract][Full Text] [Related]
7. Transdermal drug delivery devices for chronotherapy.
Hradetzky D
Med Device Technol; 2008; 19(3):45-7. PubMed ID: 18557410
[TBL] [Abstract][Full Text] [Related]
8. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
Pfister WR; Hsieh DS
Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
[TBL] [Abstract][Full Text] [Related]
9. Transdermal drug delivery.
Guy RH
Handb Exp Pharmacol; 2010; (197):399-410. PubMed ID: 20217537
[TBL] [Abstract][Full Text] [Related]
10. Evaluating elevated release liner adhesion of a transdermal drug delivery system (TDDS): a study of Daytrana™ methylphenidate transdermal system.
Wokovich AM; Shen M; Doub WH; Machado SG; Buhse LF
Drug Dev Ind Pharm; 2011 Oct; 37(10):1217-24. PubMed ID: 21438703
[TBL] [Abstract][Full Text] [Related]
11. Oral osmotically driven systems: 30 years of development and clinical use.
Malaterre V; Ogorka J; Loggia N; Gurny R
Eur J Pharm Biopharm; 2009 Nov; 73(3):311-23. PubMed ID: 19602438
[TBL] [Abstract][Full Text] [Related]
12. Role of pressure-sensitive adhesives in transdermal drug delivery systems.
Lobo S; Sachdeva S; Goswami T
Ther Deliv; 2016; 7(1):33-48. PubMed ID: 26652621
[TBL] [Abstract][Full Text] [Related]
13. Approaches for breaking the barriers of drug permeation through transdermal drug delivery.
Alexander A; Dwivedi S; Ajazuddin ; Giri TK; Saraf S; Saraf S; Tripathi DK
J Control Release; 2012 Nov; 164(1):26-40. PubMed ID: 23064010
[TBL] [Abstract][Full Text] [Related]
14. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.
Godin B; Touitou E
Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400
[TBL] [Abstract][Full Text] [Related]
15. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
Al-Qallaf B; Das DB
Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
[TBL] [Abstract][Full Text] [Related]
16. Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide.
Mutalik S; Udupa N
J Pharm Pharm Sci; 2005 Jan; 8(1):26-38. PubMed ID: 15946595
[TBL] [Abstract][Full Text] [Related]
17. Microneedles for transdermal drug delivery.
Prausnitz MR
Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
[TBL] [Abstract][Full Text] [Related]
18. Permeation enhancer strategies in transdermal drug delivery.
Marwah H; Garg T; Goyal AK; Rath G
Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
[TBL] [Abstract][Full Text] [Related]
19. Transdermal drug delivery: past progress, current status, and future prospects.
Langer R
Adv Drug Deliv Rev; 2004 Mar; 56(5):557-8. PubMed ID: 15019745
[No Abstract] [Full Text] [Related]
20. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization.
Soler LI; Boix A; Lauroba J; Colom H; Domenech J
Drug Dev Ind Pharm; 2012 Oct; 38(10):1171-8. PubMed ID: 22204649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]